Leuven, Belgium

Shrivinas Dumbre


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Shrivinas Dumbre in Antiviral Compounds

Introduction

Shrivinas Dumbre is an accomplished inventor based in Leuven, Belgium. He has made significant contributions to the field of antiviral research, particularly through his innovative work on nucleoside phosphonates. His expertise and dedication to advancing medical science have led to the development of novel compounds aimed at treating viral infections.

Latest Patents

Dumbre holds a patent for "Antiviral compounds, a process for their preparation, and their use for treating viral infections." This invention relates to novel pro-drugs of L-2'-deoxythreose nucleoside phosphonates, including phosphoramidate, phosphorodiamidate, and phospho-diester pro-drugs. The patent outlines a process for preparing these innovative prodrugs and their application in treating or preventing viral infections, particularly those caused by viruses belonging to the HBV family. He has 1 patent to his name.

Career Highlights

Shrivinas Dumbre is affiliated with K.U. Leuven Research & Development, where he collaborates with other leading researchers in the field. His work has been instrumental in advancing the understanding and treatment of viral infections, showcasing his commitment to improving public health through scientific innovation.

Collaborations

Dumbre has worked alongside notable colleagues such as Piet Herdewijn and Steven De Jonghe. Their collaborative efforts have contributed to the success of various research projects and the development of groundbreaking antiviral therapies.

Conclusion

Shrivinas Dumbre's contributions to antiviral research and his innovative patent demonstrate his significant impact on the field. His work continues to pave the way for new treatments that can help combat viral infections effectively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…